Skip to Main Content

Author Details

Mark A Gregory
University of Colorado Anschutz Medical Campus
2000
18
15
PMIDPaper TitleJournal TitlePublished Year
36259537Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation.Elife2022
30940653Targeting Glutamine Metabolism and Redox State for Leukemia Therapy.Clin Cancer Res2019
28947392Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.Exp Hematol2018
27791036ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.Proc Natl Acad Sci U S A2016
25547679Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.Clin Cancer Res2015
24891015Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.Am J Hematol2014
22941562Using functional genomics to overcome therapeutic resistance in hematological malignancies.Immunol Res2013
23757356Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.Clin Cancer Res2013
23277542Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity.Proc Natl Acad Sci U S A2013
23056582Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer.PLoS One2012
20609354Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.Cancer Cell2010
15655352The ARF tumor suppressor: keeping Myc on a leash.Cell Cycle2005
15361884p19ARF directly and differentially controls the functions of c-Myc independently of p53.Nature2004
15241487MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.Oncogene2004
14563837Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization.J Biol Chem2003
10713166c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.Mol Cell Biol2000
11039906B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation.Oncogene2000
10866684Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma.Mol Cell Biol2000
  • 1 - 18 of 18

Recommended Authors

Ashok Kumar Jayavelu
German Cancer Research Center (DKFZ)
Career Start Year 2014
Number of shared co-authors 0
Amanda L Christie
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 6
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 3
Mateusz Koptyra
Children's Hospital of Philadelphia
Career Start Year 2004
Number of shared co-authors 0
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Career Start Year 2002
Number of shared co-authors 8
Michelle J Henderson
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2002
Number of shared co-authors 0
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 0
Changchun Deng
Center for Lymphoid Malignancies, Columbia University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 3
Bill H Chang
Oregon Health and Science University
Career Start Year 1993
Number of shared co-authors 6
John Alan Diehl
Case Western Reserve University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Andrei Goga
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 0
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 5
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 0
Linda Z Penn
University of Toronto
Career Start Year 1990
Number of shared co-authors 0
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 0
Poul H Sorensen
British Columbia Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 0
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Rosalie C Sears
Oregon Health and Science University
Career Start Year 1987
Number of shared co-authors 3
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 1
Marcela Gronda
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 0
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 3
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 1
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 0
Scott H Kaufmann
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 1

Collaborators

James DeGregori
University of Colorado Anschutz Medical Campus
Co-authored papers 9
Vadym Zaberezhnyy
University of Colorado Anschutz Medical Campus
Co-authored papers 6
Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 4
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 3
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Travis Nemkov
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Biniam Adane
The Broad Institute of MIT and Harvard
Co-authored papers 2
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Co-authored papers 2
Brian J Druker
Oregon Health & Science University
Co-authored papers 1
Christopher C Porter
Emory University School of Medicine
Co-authored papers 1
Andrii I Rozhok
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Sarah Gehrke
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Catherine Pham-Danis
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Thomas O'Hare
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 1
Hae-Joon Park
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Co-authored papers 1
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Release 1.2